Inicio

Investigación e Informes

Informes técnicos, estudios y datos de mercado

Investigación e Informes
19 sept 2026•1 min de lectura
Novartis pelacarsen fails to cut major cardiovascular events in Phase 3 Lp(a)HORIZON trial
In the large Phase 3 Lp(a)HORIZON study of 8,323 patients, Novartis’ pelacarsen did not achieve a reduction in major cardiovascular events despite lowering Lp(a).
Investigación e Informes
18 sept 2026•1 min de lectura
Cochrane Review Finds Limited Evidence for Lumbar Support Belts in Low Back Pain
A Cochrane review of eight trials with over 500 adults found insufficient evidence that lumbar support belts relieve low back pain, though a modest short‑term benefit when combined with analgesics was observed.
Investigación e Informes
18 sept 2026•1 min de lectura
Ring‑type cuffless BP monitor shows 24‑hr monitoring potential for AF and HF patients
At ESC Congress 2026, SkyLabs presented clinical data indicating its ring‑type cuffless CART device can continuously monitor atrial fibrillation and heart failure patients.
Investigación e Informes
18 sept 2026•1 min de lectura
Ivonescimab Shows Overall Survival Benefit Over Keytruda in Head-to-Head NSCLC Trial
Akeso and Summit Therapeutics reported that their PD‑1×VEGF bispecific antibody ivonescimab improved overall survival versus Merck’s Keytruda in a direct comparison trial for first‑line PD‑L1‑positive NSCLC, though market reaction was muted.
Investigación e Informes
18 sept 2026•1 min de lectura
AbbVie reports positive Phase 3 results for etentamig in relapsed/refractory multiple myeloma
AbbVie announced that its dual-specific T-cell engager etentamig improved response rates and progression-free survival in heavily pre-treated multiple myeloma, with low CRS and infection rates.
Investigación e Informes
17 sept 2026•1 min de lectura
Pharmacists launch reusable digital tool for magnesium supplement counseling
A new customizable workspace, the Claude Project, lets pharmacists pre‑load guidelines and reference material to consistently advise patients on magnesium forms such as oxide, citrate, and gluconate.
Investigación e Informes
17 sept 2026•1 min de lectura
Mirtazapine-Associated Nocturia in a 56-Year-Old Diabetic Patient – Case Report
A 56‑year‑old female with diabetes reported nocturia while on mirtazapine, alongside metformin/sitagliptin, eszopiclone and escitalopram.
Investigación e Informes
17 sept 2026•1 min de lectura
Philips MR Systems Export Incorrect Diffusion Directions in Enhanced DICOM DTI Scans
Exported diffusion tensor imaging (DTI) scans from Philips MR systems using the Enhanced MR DICOM format contain incorrect diffusion direction data, preventing proper tractography processing.
Investigación e Informes
17 sept 2026•1 min de lectura
Nutrition Intervention Research for Early Cold Throat Pain and Fever: Current Status
Domestic health functional foods lack approved ingredients for directly relieving sore throat or fever, while overseas studies explore specific nutrients taken at symptom onset or pre‑emptively.
Investigación e Informes
17 sept 2026•1 min de lectura
Pharmacists navigate limited clinical evidence in recommending sore‑throat cold medicines
A Korean article highlights that pharmacists have many options for sore‑throat relief, but clear clinical trial evidence exists for only a few, leaving decisions to guidelines, approvals, and experience.
Investigación e Informes
17 sept 2026•1 min de lectura
Management of Sore Throat and Fever: Differentiating Viral Infections from Group A Streptococcal Tonsillopharyngitis
Sore throat and fever are common in acute upper respiratory infections; most are viral and self‑limiting, but group A Streptococcus can cause serious complications requiring antibiotics and careful prescription review.
Investigación e Informes
17 sept 2026•1 min de lectura
Common Cold: Symptoms, Causes and Upper Respiratory Infections Overview
The common cold presents with sore throat and fever, frequently seen in primary care and pharmacies, and involves various upper‑respiratory infections caused mainly by viruses such as rhinovirus.